physostigmine has been researched along with Behavior Disorders in 18 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 17 (94.44) | 18.7374 |
1990's | 1 (5.56) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
MIDRIO, M; XAMIN, E | 1 |
STOLIAROV, GV | 1 |
Brichcín, S; Filipová, A | 1 |
Bahro, M; Berger, M; Gann, H; Hohagen, F; Lis, S; Riemann, D; Stadmüller, G | 1 |
Enna, SJ | 1 |
Luauté, JP; Thionville, M | 1 |
Bourgeois, M | 1 |
Hussey, HH | 1 |
Gillin, JC; Huey, LY; Janowsky, DS; Kalir, HH; Kennedy, B; Mott, MA; Risch, SC; Turken, A; Ziegler, M | 1 |
Huey, LY; Janowsky, DS; Rausch, JL; Risch, SC | 1 |
Ambani, LM; Sethy, VH; Van Woert, MH | 1 |
Davis, JM | 1 |
Constantinidis, J | 1 |
Modestin, J | 1 |
Ambani, LM; Bowers, MB; Van Woert, MH | 1 |
Bilikiewicz, T; Galuszko, P | 1 |
Leczycka, K; Trembla, K | 1 |
1 review(s) available for physostigmine and Behavior Disorders
Article | Year |
---|---|
Neurobiology and pharmacology of Huntington's disease.
Topics: Brain; Carnosine; Choline O-Acetyltransferase; Cholinergic Fibers; gamma-Aminobutyric Acid; Glutamate Decarboxylase; Humans; Huntington Disease; Mental Disorders; Movement; Nerve Degeneration; Norepinephrine; Peptidyl-Dipeptidase A; Physostigmine; Receptors, Muscarinic; Receptors, Neurotransmitter; Serotonin; Tranquilizing Agents | 1977 |
3 trial(s) available for physostigmine and Behavior Disorders
Article | Year |
---|---|
Cholinergic neurotransmission, REM sleep and depression.
Topics: Adolescent; Adult; Aged; Alzheimer Disease; Brain Stem; Cholinergic Agonists; Cholinergic Fibers; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Female; Galantamine; Humans; Male; Mental Disorders; Middle Aged; Parasympathomimetics; Physostigmine; Polysomnography; Reaction Time; Receptors, Muscarinic; Sleep Stages; Sleep Wake Disorders; Sleep, REM; Succinimides; Synaptic Transmission; Tacrine | 1994 |
Central and peripheral cholinesterase inhibition: effects on anterior pituitary and sympathomimetic function.
Topics: Adrenocorticotropic Hormone; Catecholamines; Endorphins; Humans; Hydrocortisone; Male; Mental Disorders; Neostigmine; Physostigmine; Pituitary Gland, Anterior; Pituitary Hormones, Anterior; Sympathetic Nervous System | 1986 |
[Pathogenesis of delirious states].
Topics: Adult; Aged; Alcoholism; Clinical Trials as Topic; Delirium; Drug Evaluation; Female; Humans; Male; Mental Disorders; Middle Aged; Physostigmine; Psychoses, Substance-Induced; Substance Withdrawal Syndrome; Substance-Related Disorders; Tranquilizing Agents | 1974 |
14 other study(ies) available for physostigmine and Behavior Disorders
Article | Year |
---|---|
[Action of adrenaline on the partially depressed neuro-muscular transmission of eserine].
Topics: Epinephrine; Mental Disorders; Muscles; Neuromuscular Junction; Physostigmine | 1961 |
[ON ATROPINE PSYCHOSES].
Topics: Atropine; Humans; Mental Disorders; Morphine; Physostigmine; Pilocarpine; Psychoses, Substance-Induced; Psychotic Disorders; Toxicology | 1963 |
[2 years of experience with cholinergolytic comas].
Topics: Adolescent; Adult; Atropine; Coma; Female; Humans; Injections, Intramuscular; Male; Mental Disorders; Middle Aged; Physostigmine; Scopolamine | 1967 |
[Anti-cholinergic confusional states connected with chemotherapy of mental diseases: value of eserine sulfate (physostigime)].
Topics: Cognition Disorders; Confusion; Depression; Humans; Mental Disorders; Physostigmine; Psychotropic Drugs; Schizophrenia | 1978 |
[Tardive Dyskinesia induced by neuroleptics: a survey of 3140 patients in a psychiatric hospital].
Topics: Aged; Antiparkinson Agents; Basal Ganglia Diseases; Chlorpromazine; Diagnosis, Differential; Dyskinesia, Drug-Induced; Female; France; Humans; Iatrogenic Disease; Male; Mental Disorders; Middle Aged; Physostigmine; Reserpine; Retrospective Studies; Tranquilizing Agents; Tyrosine | 1977 |
Letter: Clinical observations in ECT.
Topics: Electroconvulsive Therapy; Female; Humans; Language Disorders; Male; Mental Disorders; Middle Aged; Parasympatholytics; Physostigmine | 1975 |
Editorial: Physostigmine: value in treatment of central toxic effects of anti-cholinergic drugs.
Topics: Amitriptyline; Benztropine; Brain; Doxepin; Haloperidol; Humans; Injections, Intramuscular; Mental Disorders; Parasympatholytics; Physostigmine; Thioridazine | 1975 |
A kinetic analysis and replication of decreased platelet serotonin uptake in depressed patients.
Topics: Bipolar Disorder; Blood Platelets; Depressive Disorder; Humans; Kinetics; Mental Disorders; Mood Disorders; Physostigmine; Serotonin | 1986 |
Effect of phenothiazines on central cholinergic activity.
Topics: Acetylcholine; Animals; Antipsychotic Agents; Basal Ganglia Diseases; Brain; Brain Chemistry; Chlorpromazine; Choline; Cholinesterase Inhibitors; Cholinesterases; Female; Humans; Male; Mental Disorders; Parasympathetic Nervous System; Parkinson Disease, Secondary; Physostigmine; Reserpine; Time Factors; Tremor; Trifluoperazine | 1974 |
Psychopharmacology in the aged. Use of psychotropic drugs in geriatric patients.
Topics: Aged; Antidepressive Agents; Antipsychotic Agents; Bipolar Disorder; Chlorpromazine; Depression; Dihydroergotoxine; Drug Interactions; Electroconvulsive Therapy; Gonadal Steroid Hormones; Guanethidine; Haloperidol; Humans; Lithium; Mental Disorders; Physostigmine; Psychotropic Drugs; Schizophrenia; Thiothixene; Thioxanthenes; Vitamins | 1974 |
[Monoamines and choreic syndromes].
Topics: Amines; Butyrophenones; Chorea; Diazepam; Dihydroxyphenylalanine; Dopamine; Ganglia; Globus Pallidus; Homovanillic Acid; Humans; Huntington Disease; Mental Disorders; Methyldopa; Methyltyrosines; Models, Neurological; Movement Disorders; Phenothiazines; Physostigmine; Reserpine; Thalamus; Tranquilizing Agents; Tyrosine | 1972 |
Physostigmine effects on phenothiazine-induced extrapyramidal reactions.
Topics: Adult; Antiparkinson Agents; Chlorpromazine; Drug Hypersensitivity; Extrapyramidal Tracts; Female; Handwriting; Humans; Male; Mental Disorders; Neurologic Examination; Parkinson Disease; Parkinson Disease, Secondary; Physostigmine; Salicylates; Schizophrenia; Substance-Related Disorders; Time Factors; Trifluoperazine; Tropanes | 1973 |
[Atropine coma and its therapeutic value].
Topics: Atropine; Chronic Disease; Coma; Humans; Mental Disorders; Neurotic Disorders; Physostigmine; Psychotic Disorders; Schizophrenia | 1970 |
The course and consequences of coma after huge doses of atropine.
Topics: Adult; Atropine; Coma; Humans; Mental Disorders; Middle Aged; Physostigmine | 1969 |